ODDB.org: Open Drug Database

Swissmedic Registration	69751	Date of registration	07.02.2025
Company name	Janssen-Cilag AG	Revision date
		Valid until	06.02.2030
Indication		Date of market entry
Index Therapeuticus (BSV)	07.16.10.	Revocation Date
Index Therapeuticus (Swissmedic)	07.16.10.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Lazcluze 80 mg	Filmtabletten	Coated tablets (Lazertinibum 80 mg)	L01EB09	CI
02	Lazcluze 240 mg	Filmtabletten	Coated tablets (Lazertinibum 240 mg)	L01EB09	CI

2025	©ywesee GmbH